ALLMedicine™ Menopause Center

Aug 12th, 2022 - This study consisted of a screening period and a 52 week treatment period. Safety follow up occurred 3 weeks after the last dose of study drug.

Aug 11th, 2022 - Genitourinary Syndrome of Menopause is a common condition that increases by four the risk of having a sexual dysfunction, and that affects the quality of life of women who suffer it. Those women with an active sexual life have fewer symptoms assoc...

Aug 10th, 2022 - Insomnia is frequently reported by women during menopause due to physiological changes and environmental factors and is associated with negative daytime sequelae. Due to medication side effects and patient preferences, there is increased interest ...

Aug 9th, 2022 - Compelling data have indicated menopause-associated increase in cardiovascular disease in women, while the underlying mechanisms remain largely unknown. It is established that changes of intestinal microbiota affect cardiovascular function in the ...

Aug 9th, 2022 - Menopause and related changes may be associated with frailty and contribute to higher frailty risk. This systematic review of the literature on the association between menopause and frailty combines the findings from studies of community-dwelling ...

May 17th, 2022 - Provide strategies for improving the care of perimenopausal and postmenopausal women based on the most recent published evidence. Perimenopausal and postmenopausal women. Target population will benefit from the most recent published scientific evi...

May 12th, 2022 - We studied the changes in the circulating metabolome and their relation to the menopausal hormonal shift in 17β-oestradiol and follicle-stimulating hormone levels among women transitioning from perimenopause to early postmenopause.

Apr 12th, 2022 - To provide health care providers with the best evidence on cannabis use with respect to women's health. Areas of focus include general patterns of cannabis use as well as safety of use; care for women who use cannabis; stigma; screening, brief int...

Feb 2nd, 2022 - Patients with nocturia are commonly referred to urology clinics, including many for whom a nonurological medical condition is responsible for their symptoms. The PLanning Appropriate Nocturia Evaluation and Treatment (PLANET) study was established...

Dec 14th, 2021 - Provide strategies for improving the care of perimenopausal and postmenopausal women based on the most recent published evidence. Perimenopausal and postmenopausal women. Target population will benefit from the most recent published scientific evi...

Aug 12th, 2022 - This study consisted of a screening period and a 52 week treatment period. Safety follow up occurred 3 weeks after the last dose of study drug.

Aug 11th, 2022 - Genitourinary Syndrome of Menopause is a common condition that increases by four the risk of having a sexual dysfunction, and that affects the quality of life of women who suffer it. Those women with an active sexual life have fewer symptoms assoc...

Aug 9th, 2022 - Hemangioblastomas of the cerebellum, brainstem and spinal cord are frequent tumors in patients with von Hippel-Lindau (VHL) disease. Rarely, these lesions also affect the cerebrum. Patients often have multiple lesions, many of which are associated...

Aug 5th, 2022 - The definition of Genitourinary Syndrome of Menopause (GSM) is the decline of estrogens during menopause results in symptoms and clinical signs from both systems. Estrogen and other hormones production decrease after menopause because the ovaries ...

Aug 5th, 2022 - Background: Annually, more than 25,500 women develop ovarian cancer (OC) and more than 16,000 die of this disease in the United States. Women at high genetic risk of OC have a much higher lifetime risk of developing OC than women in the general po...

Aug 8th, 2022 - Hormone therapy remains a topic for debate, but a constant in the 2 decades since the Women’s Health Initiative has been the demonstrated effectiveness for relief of vasomotor symptoms and reduction of fracture risk in menopausal women, according.

Aug 8th, 2022 - Hormone therapy remains a topic for debate, but a constant in the 2 decades since the Women's Health Initiative has been the demonstrated effectiveness for relief of vasomotor symptoms and reduction of fracture risk in menopausal women, according ...

Aug 5th, 2022 - CORRECTED August 8, 2022 // An earlier version of this article misidentified the location of the Marijuana Investigations for Neuroscientific Discovery program. The MIND program is located at McLean Hospital in Belmont, Mass., an affiliate of Harv...

Jul 27th, 2022 - Purpose of Review: Previous studies have demonstrated associations between the physiological changes accompanied with the onset of menopause and increased atherosclerotic cardiovascular disease (ASCVD) risk. This review surveys current literature ...

Jul 26th, 2022 - This transcript has been edited for clarity. Many women with type 1 and type 2 diabetes have sexual problems. In fact, up to approximately one third of women experience complaints of sexual desire, arousal, and even pain with sexual activity or ju...